Share

August 2021; 11 (4) Review

Molecular Biomarkers for Spinal Muscular Atrophy

A Systematic Review

Angela Navarrete-Opazo, Sheldon Garrison, Mindy Waite
First published May 29, 2020, DOI: https://doi.org/10.1212/CPJ.0000000000000872
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
222

Share

Article Information

vol. 11 no. 4 e524-e536
DOI: 
https://doi.org/10.1212/CPJ.0000000000000872
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received November 19, 2019
  • Accepted March 5, 2020
  • First Published May 29, 2020.

Article Versions

Copyright & Usage: 
© 2021 American Academy of Neurology

Author Disclosures

    1. Angela Navarrete-Opazo, MD, PhD,
    2. Sheldon Garrison, PhD and
    3. Mindy Waite, PhD
  1. Angela Navarrete-Opazo, MD, PhD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Sheldon Garrison, PhD and
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) Editorial Board Member, Technology Transfer and Entrepreneurship, 2018- present.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. (1) Advocate Aurora Health - Aurora Research Institute, Research Scientist, 2017-present

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) Advocate Aurora Health Foundation (no grant number - internal) (2) Ed Howe Center for Health Care Transformation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Mindy Waite, PhD
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. (1) Advocate Aurora Health, research scientist, 5 years, (2) University of Wisconsin - Milwaukee, associate lecturer, 2.5 years

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Aurora Research Institute, Advocate Aurora Health, Milwaukee, WI.
  1. Correspondence
    Dr. Navarrete-Opazo angela.navarreteopazo{at}aurora.org

Article usage

Article usage: May 2020 to October 2023

AbstractFullPdfSource
May 20203601Highwire
Jun 2020156012Highwire
Jul 20209402Highwire
Aug 202017307Highwire
Sep 20207309Highwire
Oct 20205001Highwire
Nov 20203905Highwire
Dec 20204801Highwire
Jan 20214906Highwire
Feb 20213805Highwire
Mar 20213505Highwire
Apr 20214208Highwire
May 20213600Highwire
Jun 20214404Highwire
Jul 202151010Highwire
Aug 20211101719Highwire
Sep 20213403633Highwire
Oct 202123356Highwire
Nov 202115235Highwire
Dec 202114323Highwire
Jan 2022125104Highwire
Feb 20229933Highwire
Mar 20226124Highwire
Apr 20225178Highwire
May 20226366Highwire
Jun 20224906Highwire
Jul 20224379Highwire
Aug 20226716Highwire
Sep 20227611Highwire
Oct 20226904Highwire
Nov 202212401Highwire
Dec 20225411Highwire
Jan 202310956Highwire
Feb 20238601Highwire
Mar 20237144Highwire
Apr 20234154Highwire
May 20235410Highwire
Jun 20235912Highwire
Jul 20235707Highwire
Aug 20234611Highwire
Sep 20232602Highwire
Oct 20233600Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles